open access

Vol 8, No 5 (2019)
ORIGINAL ARTICLES
Published online: 2019-11-28
Get Citation

Anthropometric, metabolic and clinical factors associated with diabetes and prediabetes prevalence in women aged 65–74 living in central Poland

Tadeusz Dereziński, Dorota Zozulińska-Ziółkiewicz, Aleksandra Uruska, Mariusz Dąbrowski
DOI: 10.5603/DK.2019.0022
·
Clinical Diabetology 2019;8(5):238-247.

open access

Vol 8, No 5 (2019)
ORIGINAL ARTICLES
Published online: 2019-11-28

Abstract

Background. Prevalence of type 2 diabetes mellitus is rising worldwide. Similar trend is also observed in Poland, especially in elderly population. The aim of this cross-sectional study was to assess prevalence and to identify anthropometric, metabolic and clinical factors associated with diabetes and prediabetes among women at early elderliness living in central Poland. Methods. 364 women aged 65–74 years, were included into the study. In all patients a history of diabetes and cardiovascular disease was obtained, blood pressure and anthropometric measurements were performed, blood samples for laboratory tests (fasting plasma glucose, lipid metabolism and creatinine) were drawn, ankle/brachial index was calculated, abdominal ultrasound with abdominal aorta diameter was performed and carotid intima/media thickness was measured. Data were collected during March and April 2012 in Gniewkowo, the rural-urban municipality in central Poland. Results. 98 women had diabetes (25 de novo) and 94 ones had prediabetes (81 de novo). Waist circumference, BMI, lipid abnormalities as well as anthropometric and metabolic indices: waist-to-height ratio (WHtR), triglycerides/HDL cholesterol ratio and visceral adiposity index (VAI) were significantly associated with abnormal glucose metabolism. Backward stepwise logistic regression analysis identified WHtR as the best single indicator of patients with diabetes, while again WHtR and VAI were the only independent indicators of any type of impaired glucose metabolism. Conclusions. Abnormal glucose metabolism is highly prevalent among women at early elderliness, especially in those with visceral obesity and abnormal lipid metabolism. Anthropometric and metabolic indices (WHtR and VAI) were better indicators of impaired glucose metabolism compared to separate measurements of single parameters.

Abstract

Background. Prevalence of type 2 diabetes mellitus is rising worldwide. Similar trend is also observed in Poland, especially in elderly population. The aim of this cross-sectional study was to assess prevalence and to identify anthropometric, metabolic and clinical factors associated with diabetes and prediabetes among women at early elderliness living in central Poland. Methods. 364 women aged 65–74 years, were included into the study. In all patients a history of diabetes and cardiovascular disease was obtained, blood pressure and anthropometric measurements were performed, blood samples for laboratory tests (fasting plasma glucose, lipid metabolism and creatinine) were drawn, ankle/brachial index was calculated, abdominal ultrasound with abdominal aorta diameter was performed and carotid intima/media thickness was measured. Data were collected during March and April 2012 in Gniewkowo, the rural-urban municipality in central Poland. Results. 98 women had diabetes (25 de novo) and 94 ones had prediabetes (81 de novo). Waist circumference, BMI, lipid abnormalities as well as anthropometric and metabolic indices: waist-to-height ratio (WHtR), triglycerides/HDL cholesterol ratio and visceral adiposity index (VAI) were significantly associated with abnormal glucose metabolism. Backward stepwise logistic regression analysis identified WHtR as the best single indicator of patients with diabetes, while again WHtR and VAI were the only independent indicators of any type of impaired glucose metabolism. Conclusions. Abnormal glucose metabolism is highly prevalent among women at early elderliness, especially in those with visceral obesity and abnormal lipid metabolism. Anthropometric and metabolic indices (WHtR and VAI) were better indicators of impaired glucose metabolism compared to separate measurements of single parameters.
Get Citation

Keywords

diabetes; prediabetes; obesity; anthropometric parameters; metabolic parameters

About this article
Title

Anthropometric, metabolic and clinical factors associated with diabetes and prediabetes prevalence in women aged 65–74 living in central Poland

Journal

Clinical Diabetology

Issue

Vol 8, No 5 (2019)

Pages

238-247

Published online

2019-11-28

DOI

10.5603/DK.2019.0022

Bibliographic record

Clinical Diabetology 2019;8(5):238-247.

Keywords

diabetes
prediabetes
obesity
anthropometric parameters
metabolic parameters

Authors

Tadeusz Dereziński
Dorota Zozulińska-Ziółkiewicz
Aleksandra Uruska
Mariusz Dąbrowski

References (31)
  1. International Diabetes Federation. 2017. IDF Diabetes Atlas. Eighth Edition. http://diabetesatlas.org/resources/2017-atlas.html (dostęp z dnia 2019.07.15).
  2. Walicka M, Chlebus M, Brzozowska M, et al. Prevalence of diabetes in Poland in the years 2010–2014. Clin Diabetol. 2016; 4(6): 232–237.
  3. Sinclair A, Dunning T, Rodriguez-Mañas L. Diabetes in older people: new insights and remaining challenges. Lancet Diabetes Endocrinol. 2015; 3(4): 275–285.
  4. American Diabetes Association. 4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes — 2019. Diabetes Care. 2019; 42(Suppl 1): S34–S45.
  5. Central Statistical Office. Life expectancy tables of Poland 2016. Statistical Publishing Establishment. Warszawa 2017.
  6. Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9): 604–612.
  7. Diabetes Poland. 2019 Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clin Diabetol. 2019; 8(1): 1–95. .
  8. Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120(16): 1640–1645.
  9. Amato MC, Giordano C, Galia M, et al. AlkaMeSy Study Group. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010; 33(4): 920–922.
  10. Amato MC, Giordano C, Pitrone M, et al. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis. 2011; 10: 183.
  11. Salazar MR, Carbajal HA, Espeche WG, et al. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardiol. 2012; 109(12): 1749–1753.
  12. Ashwell M, Gibson S. Waist-to-height ratio as an indicator of 'early health risk': simpler and more predictive than using a 'matrix' based on BMI and waist circumference. BMJ Open. 2016; 6(3): e010159.
  13. National Center for Chronic Disease Prevention and Health Promotion. 2017. National Diabetes Statistics Report, 2017. Estimates of diabetes and its burden in the United States. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf (dostęp z dnia 2019.07.15).
  14. Public Health Agency of Canada. Diabetes in Canada: Facts and figures from a public health perspective. https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/cd-mc/publications/diabetes-diabete/facts-figures-faits-chiffres-2011/pdf/facts-figures-faits-chiffres-eng.pdf (dostęp z dnia 2019.07.15).
  15. Diabetes UK. 2016. Facts and Stats. https://diabetes-resources-production.s3-eu-west-1.amazonaws.com/diabetes-storage/migration/pdf/DiabetesUK_Facts_Stats_Oct16.pdf (dostęp z dnia 2019.07.15).
  16. Chen GY, Li L, Dai F, et al. Prevalence of and Risk Factors for Type 2 Diabetes Mellitus in Hyperlipidemia in China. Med Sci Monit. 2015; 21: 2476–2484.
  17. Liu L, Simon B, Shi J, et al. Impact of diabetes mellitus on risk of cardiovascular disease and all-cause mortality: Evidence on health outcomes and antidiabetic treatment in United States adults. World J Diabetes. 2016; 7(18): 449–461.
  18. Huang Yi, Cai X, Chen P, et al. Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis. Ann Med. 2014; 46(8): 684–692.
  19. Taimour S, Zarrouk M, Holst J, et al. Aortic diameter at age 65 in men with newly diagnosed type 2 diabetes. Scand Cardiovasc J. 2017; 51(4): 202–206.
  20. Prenner SB, Chirinos JA. Arterial stiffness in diabetes mellitus. Atherosclerosis. 2015; 238(2): 370–379.
  21. Hua S, Loehr LR, Tanaka H, et al. Ankle-brachial index and incident diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Cardiovasc Diabetol. 2016; 15(1): 163.
  22. Gomez-Marcos MA, Gomez-Sanchez L, Patino-Alonso MC, et al. MARK Group. Association between markers of glycemia and carotid intima-media thickness: the MARK study. BMC Cardiovasc Disord. 2016; 16(1): 203.
  23. Giannini S, Bardini G, Dicembrini I, et al. Lipid levels in obese and nonobese subjects as predictors of fasting and postload glucose metabolism. J Clin Lipidol. 2012; 6(2): 132–138.
  24. Wang Y, He S, He J, et al. Predictive value of visceral adiposity index for type 2 diabetes mellitus: A 15-year prospective cohort study. Herz. 2015; 40 Suppl 3: 277–281.
  25. Dereziński T, Zozulińska-Ziółkiewicz D, Uruska A, et al. Visceral adiposity index as a useful tool for the assessment of cardiometabolic disease risk in women aged 65 to 74 living in central Poland. Diabetes Metab Res Rev. 2018; 34(8): e3052.
  26. Diabetes Prevention Program Research Group. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2012; 35(4): 731–737.
  27. Ley SH, Hamdy O, Mohan V, et al. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet. 2014; 383(9933): 1999–2007.
  28. Balk EM, Earley A, Raman G, et al. Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med. 2015; 163(6): 437–451.
  29. Breeze PR, Thomas C, Squires H, et al. The impact of Type 2 diabetes prevention programmes based on risk-identification and lifestyle intervention intensity strategies: a cost-effectiveness analysis. Diabet Med. 2017; 34(5): 632–640.
  30. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321(7258): 405–412.
  31. Rao Kondapally Seshasai S, Kaptoge S, Thompson A, et al. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011; 364(9): 829–841.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl